The United States Protein Drugs Market is supported by substantial biopharmaceutical research and development activities, high healthcare spending, and the strong presence of leading biotechnology and pharmaceutical companies. Increasing adoption of recombinant proteins, monoclonal antibodies, peptide-based therapies, and other innovative biologics is contributing to the expansion of treatment...